Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0X0IT
|
|||
| Former ID |
DNC002823
|
|||
| Drug Name |
Diphenylacetic Acid
|
|||
| Synonyms |
DIPHENYLACETIC ACID; 2,2-diphenylacetic acid; 117-34-0; Diphenylethanoic acid; Acetic acid, diphenyl-; Benzeneacetic acid, .alpha.-phenyl-; 1,1-Diphenylacetic acid; UNII-658NCZ0NKO; Diphenyl-acetic acid; alpha-Toluic acid, alpha-phenyl-; Benzeneacetic acid, alpha-phenyl-; EINECS 204-185-0; NSC 120417; BRN 1910978; 658NCZ0NKO; AI3-23777; CHEBI:41967; PYHXGXCGESYPCW-UHFFFAOYSA-N; .alpha.,.alpha.-Diphenylacetic acid; MFCD00004251; .alpha.-Toluic acid, .alpha.-phenyl-; A-Toluic Acid, A-Phenyl-; Diphenylacetic acid, 99+%
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C14H12O2
|
|||
| Canonical SMILES |
C1=CC=C(C=C1)C(C2=CC=CC=C2)C(=O)O
|
|||
| InChI |
1S/C14H12O2/c15-14(16)13(11-7-3-1-4-8-11)12-9-5-2-6-10-12/h1-10,13H,(H,15,16)
|
|||
| InChIKey |
PYHXGXCGESYPCW-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 117-34-0
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID |
74360, 414826, 607065, 3133094, 7700432, 7886980, 8155852, 10505121, 14916696, 24866907, 24888248, 24893604, 29196560, 29227035, 33316865, 46507444, 47193691, 48035468, 49747368, 49861843, 51074597, 53790061, 56367714, 57324936, 57935789, 80579499, 85085652, 85171830, 87567475, 88297503, 104248360, 104317555, 104668006, 111677853, 114916319, 117605671, 117688946, 118053639, 124812978, 124953368, 125338782, 126541105, 126676899, 128985948, 131171983, 131288053, 131363907, 134973181, 135857385, 137008256
|
|||
| ChEBI ID |
CHEBI:41967
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Cathepsin B (CTSB) | Target Info | Inhibitor | [1] |
| KEGG Pathway | Lysosome | |||
| Antigen processing and presentation | ||||
| NetPath Pathway | TCR Signaling Pathway | |||
| IL2 Signaling Pathway | ||||
| Reactome | Collagen degradation | |||
| Trafficking and processing of endosomal TLR | ||||
| Assembly of collagen fibrils and other multimeric structures | ||||
| MHC class II antigen presentation | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | How many drug targets are there Nat Rev Drug Discov. 2006 Dec;5(12):993-6. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.